Titre du document / Document title

Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder

Auteur(s) / Author(s)

CALIYURT Okan ⁽¹⁾ ; GUDUCU Funda ⁽¹⁾ ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Psychiatry Department, Trakya University, School of Medicine, Edirne 22030, TURQUIE

Résumé / Abstract

Background: Total or partial sleep deprivation was showed to have rapid antidepressive effects in depression. Sleep deprivation therapy in major depression constitutes insufficient antidepressive treatment response and depressive symptoms reoccur after one night of recovery. Combination of antidepressant medication with sleep deprivation therapy is generally indicated. These combination therapies were found more favorable overall therapeutic effect than antidepressive monotherapy. Methods: In this study, we examined the Quality of Life changes with the antidepressive therapy using partial sleep deprivation plus sertraline and sertraline monotherapy in patients with major depressive disorder. Thirteen patients received six partial sleep deprivation therapies in addition to sertraline, that sleep schedule in deprivation nights started at 11:00-12:00 p.m. to 03:00 a.m. and 11 patients treated with sertraline monotherapy as a control group. Quality of Life was evaluated with the WHOQOL-100, depression and the accompanying anxiety were also assessed at baseline and at the end of the 4th week. Results: Patients treated with combination therapy improved significantly and more rapidly. Rapid improvement in quality of life in major depressive disorder was showed in patients treated with combination of late partial sleep deprivation and sertraline. Limitations: Small sample size, the lack of placebo group and short duration of the study are the main limitations. Conclusions: In clinical practice, QOL improvement can be accelerated using combination of partial sleep deprivation with the sertraline therapy.

Revue / Journal Title

Journal of affective disorders   ISSN 0165-0327   CODEN JADID7 

Source / Source

2005, vol. 88, n^o1, pp. 75-78 [4 page(s) (article)] (24 ref.)

Langue / Language

Anglais

Editeur / Publisher

Elsevier, Amsterdam, PAYS-BAS  (1979) (Revue)

Mots-clés anglais / English Keywords

Neurotransmitter ; Chemotherapy ; Neurological disorder ; Nervous system diseases ; Mood disorder ; Selective serotonin reuptake inhibitor ; Serotonin ; Reuptake inhibitor ; Psychotropic ; Sleep disorder ; Sleep wake cycle ; Human ; Combined treatment ; Deprivation ; Depression ; Quality of life ; Sertraline ; Antidepressant agent ; Treatment ; Insomnia ; Sleep ;

Mots-clés français / French Keywords

Naphtylamine dérivé ; Neurotransmetteur ; Chimiothérapie ; Trouble neurologique ; Système nerveux pathologie ; Trouble humeur ; Inhibiteur sélectif recapture sérotonine ; Sérotonine ; Inhibiteur recapture ; Psychotrope ; Trouble sommeil ; Cycle veille sommeil ; Homme ; Traitement associé ; Privation ; Etat dépressif ; Qualité vie ; Sertraline ; Antidépresseur ; Traitement ; Insomnie ; Sommeil ;

Mots-clés espagnols / Spanish Keywords

Neurotransmisor ; Quimioterapia ; Trastorno neurológico ; Sistema nervioso patología ; Trastorno humor ; Inhibidor selectivo recaptura serotonin ; Serotonina ; Inhibidor recaptura ; Psicotropo ; Trastorno sueño ; Ciclo sueño vigilia ; Hombre ; Tratamiento asociado ; Privación ; Estado depresivo ; Calidad vida ; Sertralina ; Antidepresor ; Tratamiento ; Insomnio ; Sueño ;

Mots-clés d'auteur / Author Keywords

Quality of life ; Depression ; Sleep deprivation therapy ; Sertraline ;

Localisation / Location

INIST-CNRS, Cote INIST : 18006, 35400013191375.0090